These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36503714)

  • 1. Quantifying the changes in the tumour vascular micro-environment in spinal metastases treated with stereotactic body radiotherapy - a single arm prospective study.
    Vellayappan B; Cheong D; Singbal S; Tey J; Yang Soon Y; Nang Leong C; Wong A; Lwin S; Hung Lee C; Periasamy P; Lo S; Kumar N
    Radiol Oncol; 2022 Dec; 56(4):525-534. PubMed ID: 36503714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early magnetic resonance imaging biomarkers to predict local control after high dose stereotactic body radiotherapy for patients with sarcoma spine metastases.
    Spratt DE; Arevalo-Perez J; Leeman JE; Gerber NK; Folkert M; Taunk NK; Alektiar KM; Karimi S; Lyo JK; Tap WD; Bilsky MH; Laufer I; Yamada Y; Osborne JR
    Spine J; 2016 Mar; 16(3):291-8. PubMed ID: 26325017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation.
    Jawad MS; Fahim DK; Gerszten PC; Flickinger JC; Sahgal A; Grills IS; Sheehan J; Kersh R; Shin J; Oh K; Mantel F; Guckenberger M;
    J Neurosurg Spine; 2016 Jun; 24(6):928-36. PubMed ID: 26895526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spine stereotactic body radiotherapy for renal cell cancer spinal metastases: analysis of outcomes and risk of vertebral compression fracture.
    Thibault I; Al-Omair A; Masucci GL; Masson-Côté L; Lochray F; Korol R; Cheng L; Xu W; Yee A; Fehlings MG; Bjarnason GA; Sahgal A
    J Neurosurg Spine; 2014 Nov; 21(5):711-8. PubMed ID: 25170656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT based quantitative measures of the stability of fractured metastatically involved vertebrae treated with spine stereotactic body radiotherapy.
    Hardisty M; Wright T; Campbell M; Burke M; Atenafu E; Cawricz M; Caldwell C; Yee A; Sahgal A; Whyne C
    Clin Exp Metastasis; 2020 Oct; 37(5):575-584. PubMed ID: 32643007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vertebral compression fracture risk after stereotactic body radiotherapy for spinal metastases.
    Boehling NS; Grosshans DR; Allen PK; McAleer MF; Burton AW; Azeem S; Rhines LD; Chang EL
    J Neurosurg Spine; 2012 Apr; 16(4):379-86. PubMed ID: 22225488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal tissue complication probability of vertebral compression fracture after stereotactic body radiotherapy for de novo spine metastasis.
    Chen X; Gui C; Grimm J; Huang E; Kleinberg L; Lo L; Sciubba D; Khan M; Redmond KJ
    Radiother Oncol; 2020 Sep; 150():142-149. PubMed ID: 32540335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Pilot Study Evaluating the Use of Dynamic Contrast-Enhanced Perfusion MRI to Predict Local Recurrence After Radiosurgery on Spinal Metastases.
    Kumar KA; Peck KK; Karimi S; Lis E; Holodny AI; Bilsky MH; Yamada Y
    Technol Cancer Res Treat; 2017 Dec; 16(6):857-865. PubMed ID: 28449626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
    Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
    J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local response and pathologic fractures following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy for spinal metastases - a randomized controlled trial.
    Sprave T; Verma V; Förster R; Schlampp I; Hees K; Bruckner T; Bostel T; El Shafie RA; Welzel T; Nicolay NH; Debus J; Rief H
    BMC Cancer; 2018 Aug; 18(1):859. PubMed ID: 30170568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for vertebral compression fracture after spine stereotactic body radiation therapy: Long-term results of a prospective phase 2 study.
    Mantel F; Sweeney RA; Klement RJ; Hawkins MA; Belderbos J; Ahmed M; Toussaint A; Polat B; Flentje M; Guckenberger M
    Radiother Oncol; 2019 Dec; 141():62-66. PubMed ID: 31526672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of different fractions in stereotactic body radiotherapy for spinal metastases: A systematic review.
    Gong Y; Xu L; Zhuang H; Jiang L; Wei F; Liu Z; Li Y; Yu M; Ni K; Liu X
    Cancer Med; 2019 Oct; 8(14):6176-6184. PubMed ID: 31489788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiotherapy for spine metastases: a review of 24 Gy in 2 daily fractions.
    Nguyen EK; Ruschin M; Zhang B; Soliman H; Myrehaug S; Detsky J; Chen H; Sahgal A; Tseng CL
    J Neurooncol; 2023 May; 163(1):15-27. PubMed ID: 37155133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk-adapted stereotactic body radiotherapy for patients with cervical spinal metastases.
    Wang HH; Tian SS; Yang JM; Sun BS; Chen Y; Song YC; Dong Y; Wang JS; Yuan ZY; Cui YL; Meng MB
    Cancer Sci; 2022 Dec; 113(12):4277-4288. PubMed ID: 36056609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging-Based Outcomes for 24 Gy in 2 Daily Fractions for Patients with de Novo Spinal Metastases Treated With Spine Stereotactic Body Radiation Therapy (SBRT).
    Tseng CL; Soliman H; Myrehaug S; Lee YK; Ruschin M; Atenafu EG; Campbell M; Maralani P; Yang V; Yee A; Sahgal A
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):499-507. PubMed ID: 30003994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vertebral compression fracture (VCF) after spine stereotactic body radiation therapy (SBRT): analysis of predictive factors.
    Cunha MV; Al-Omair A; Atenafu EG; Masucci GL; Letourneau D; Korol R; Yu E; Howard P; Lochray F; da Costa LB; Fehlings MG; Sahgal A
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e343-9. PubMed ID: 22658511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases: Who Will Benefit the Most from SBRT?
    Park HJ; Kim HJ; Won JH; Lee SC; Chang AR
    Technol Cancer Res Treat; 2015 Apr; 14(2):159-67. PubMed ID: 24502552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and preliminary clinical results of linac-based Stereotactic Body Radiotherapy for spinal metastases using a dedicated contouring and planning system.
    Giaj-Levra N; Niyazi M; Figlia V; Napoli G; Mazzola R; Nicosia L; Corradini S; Ruggieri R; Minniti G; Alongi F
    Radiat Oncol; 2019 Oct; 14(1):184. PubMed ID: 31655620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic body radiation therapy for benign spine tumors: is dose de-escalation appropriate?
    Kalash R; Glaser SM; Flickinger JC; Burton S; Heron DE; Gerszten PC; Engh JA; Amankulor NM; Vargo JA
    J Neurosurg Spine; 2018 Aug; 29(2):220-225. PubMed ID: 29799334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective multicentre feasibility study of stereotactic body radiotherapy in Japanese patients with spinal metastases.
    Ito K; Furuya T; Shikama N; Nihei K; Tanaka H; Kumazaki Y; Nishimura H; Karasawa K
    Jpn J Clin Oncol; 2019 Dec; 49(11):999-1003. PubMed ID: 31665478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.